Surgical Innovations Group (LSE:SUN) Debt-to-Equity : 0.16 (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Debt-to-Equity?

Surgical Innovations Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.61 Mil. Surgical Innovations Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £1.05 Mil. Surgical Innovations Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £10.48 Mil. Surgical Innovations Group's debt to equity for the quarter that ended in Dec. 2023 was 0.16.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Surgical Innovations Group's Debt-to-Equity or its related term are showing as below:

LSE:SUN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.19 Max: 0.82
Current: 0.16

During the past 13 years, the highest Debt-to-Equity Ratio of Surgical Innovations Group was 0.82. The lowest was 0.01. And the median was 0.19.

LSE:SUN's Debt-to-Equity is ranked better than
57.65% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs LSE:SUN: 0.16

Surgical Innovations Group Debt-to-Equity Historical Data

The historical data trend for Surgical Innovations Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Debt-to-Equity Chart

Surgical Innovations Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.17

0.30

0.26

0.20

0.16

Surgical Innovations Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.26	0.22	0.20	0.18	0.16

Competitive Comparison of Surgical Innovations Group's Debt-to-Equity

For the Medical Devices subindustry, Surgical Innovations Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgical Innovations Group's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Debt-to-Equity falls into.

Surgical Innovations Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Surgical Innovations Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.611	+	1.051)	/	10.484
	=	0.16

Surgical Innovations Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.611	+	1.051)	/	10.484
	=	0.16

Surgical Innovations Group (LSE:SUN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Surgical Innovations Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgical Innovations Group (LSE:SUN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ

Website

https://www.sigroupplc.com

Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.